Literature DB >> 21553090

Comparison of dopamine turnover, dopamine influx constant and activity ratio of striatum and occipital brain with ¹⁸F-dopa brain PET in normal controls and patients with Parkinson's disease.

Liane Oehme1, Maria Perick, Bettina Beuthien-Baumann, Martin Wolz, Alexander Storch, Matthias Löhle, Birgit Herting, Jens Langner, Jörg van den Hoff, Heinz Reichmann, Jörg Kotzerke.   

Abstract

PURPOSE: The aim of the study was to estimate normal ranges and test-retest measures for various parameters characterising dopamine metabolism from a prolonged (18)F-dopa positron emission tomography (PET) measurement using a reference tissue model and compare their value for the detection of early Parkinson's disease (PD).
METHODS: Healthy volunteers (n = 9) and patients (n = 36) in an early stage of PD underwent an (18)F-dopa PET measurement lasting 4 h. The influx rate constant k(occ) and the effective distribution volume ratio (EDVR, its inverse is an indicator for dopamine turnover) were estimated by a graphical approach using dynamic data in the striatum and, as a reference region, the occipital cortex. Furthermore, ratios of activity concentrations between striatum and occipital brain taken for three time intervals completed the data analysis. All parameters were determined both in eight small volumes of interest placed in the striatum as well as averaged for caudate nucleus and putamen. For the control group, reproducibility was checked in a second study 3 months later and ranges for normal values were derived from mean ± 2 standard deviations. Receiver-operating characteristic (ROC) analyses were performed to assess the value of the parameters for diagnostic purposes.
RESULTS: Patients with early-stage PD and healthy volunteers could be separated by the values of the putamen, not the caudate nucleus. The normal ranges of the putamen were 0.0151-0.0216/min for the influx rate constant k(occ) and 2.02-3.00 for EDVR. For the various time intervals used the striato-occipital ratios yielded 2.24-3.06, 2.43-3.42 and 2.35-3.21, respectively. Patients were characterised by significantly lower values (p < 0.001) and significant differences between ipsi- and contralateral sides (p < 0.001) with regard to their clinical symptoms and a rostrocaudal gradient. EDVR as well as k(occ) for the putamen were able to effectively differentiate between groups (sensitivity >97%, specificity 100%). In contrast, striato-occipital ratios showed a sensitivity of about only 85%.
CONCLUSION: For clinical applications, our data do not demonstrate any superiority of the EDVR determination compared to influx rate constant, while requiring long and tedious acquisition protocols. The normal range estimates do not represent absolute quantitative measures for dopamine metabolism but are specific for the chosen acquisition and processing procedures.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21553090     DOI: 10.1007/s00259-011-1819-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  24 in total

1.  A reversible tracer analysis approach to the study of effective dopamine turnover.

Authors:  V Sossi; D J Doudet; J E Holden
Journal:  J Cereb Blood Flow Metab       Date:  2001-04       Impact factor: 6.200

2.  Optimized list-mode acquisition and data processing procedures for ACS2 based PET systems.

Authors:  Jens Langner; Paul Bühler; Uwe Just; Christian Pötzsch; Edmund Will; Jörg van den Hoff
Journal:  Z Med Phys       Date:  2006       Impact factor: 4.820

Review 3.  Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms.

Authors:  P Cumming; A Gjedde
Journal:  Synapse       Date:  1998-05       Impact factor: 2.562

4.  Increase in dopamine turnover occurs early in Parkinson's disease: evidence from a new modeling approach to PET 18 F-fluorodopa data.

Authors:  Vesna Sossi; Raúl de La Fuente-Fernández; James E Holden; Doris J Doudet; Jess McKenzie; A J Stoessl; T J Ruth
Journal:  J Cereb Blood Flow Metab       Date:  2002-02       Impact factor: 6.200

5.  Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations.

Authors:  C S Patlak; R G Blasberg
Journal:  J Cereb Blood Flow Metab       Date:  1985-12       Impact factor: 6.200

6.  Loss of metabolites from monkey striatum during PET with FDOPA.

Authors:  P Cumming; O L Munk; D Doudet
Journal:  Synapse       Date:  2001-09-01       Impact factor: 2.562

7.  Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls.

Authors:  Pekka Jokinen; Hans Helenius; Elina Rauhala; Anna Brück; Olli Eskola; Juha O Rinne
Journal:  J Nucl Med       Date:  2009-05-14       Impact factor: 10.057

8.  The simplified reference tissue model for SPECT/PET brain receptor studies. Interpretation of its parameters.

Authors:  R Buchert; F Thiele
Journal:  Nuklearmedizin       Date:  2008       Impact factor: 1.379

9.  Aspects of 6-[18F]fluoro-L-DOPA preparation. Deuterochloroform as a substitute solvent for Freon 11.

Authors:  F Füchtner; J Zessin; P Mäding; F Wüst
Journal:  Nuklearmedizin       Date:  2008       Impact factor: 1.379

10.  Factors affecting the specific activity of [18F]fluoride from a [18O]water target.

Authors:  F Füchtner; S Preusche; P Mäding; J Zessin; J Steinbach
Journal:  Nuklearmedizin       Date:  2008       Impact factor: 1.379

View more
  3 in total

1.  Dual time point method for the quantification of irreversible tracer kinetics: A reference tissue approach applied to [18F]-FDOPA brain PET.

Authors:  I Lopes Alves; Sanne K Meles; Antoon Tm Willemsen; Rudi A Dierckx; Ana M Marques da Silva; Klaus L Leenders; Michel Koole
Journal:  J Cereb Blood Flow Metab       Date:  2016-12-19       Impact factor: 6.200

2.  Prediction of Parkinson's disease subsequent to severe depression: a ten-year follow-up study.

Authors:  Uwe Walter; Robert Heilmann; Lara Kaulitz; Tino Just; Bernd Joachim Krause; Reiner Benecke; Jacqueline Höppner
Journal:  J Neural Transm (Vienna)       Date:  2014-09-14       Impact factor: 3.575

3.  Comparison of 6-[18F]FDOPA PET with Nigrosome 1 detection in patients with parkinsonism.

Authors:  Enrico Michler; Daniel Kaiser; Kiriaki Eleftheriadou; Björn Falkenburger; Jörg Kotzerke; Sebastian Hoberück
Journal:  EJNMMI Res       Date:  2021-02-15       Impact factor: 3.138

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.